Download the Article: 'The changing face of pharma in the precision era'

Blue Latitude Health speaks to Nancy Brandt, a Senior Leader in GLobal Medical Information at a top 20 biopharma organisation. Here, she reveals that pharmaceutical companies need to do to prepare to bring precision medicines to market and how she is ensuring the patient is consulted every step of the way

Please enter your details so we can email you the content:

First Name Last Name Email Company Job Title Sign up for our monthly newsletter. You can unsubscribe at any time. Please see our Privacy Policy for more details. I agree to receive email content from Blue Latitude Network in accordance with the Privacy Policy. You can unsubscribe at any time.

Other articles you may be interested in

A uniquely English genomic medicine service

Blue Latitude Health speaks to Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market.

Six factors that drive a multiple sclerosis patient's choice of disease-modifying therapy

Precision medicine from concept to clinic

In our latest edition of ‘Perspective’ magazine, we examine the challenges and opportunities for several stakeholders impacted by the dawn of precision medicine

Precision paediatrics: Treating patients with CAR-T

Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking CAR-T therapy for the first patient in Europe, and how the centre of excellence has adapted to make precision medicine a reality.

Sign up for our newsletters to receive...